Quantcast

Latest Ciprofloxacin Stories

2009-09-03 11:42:00

PITTSBURGH, Sept. 3 /PRNewswire/ -- At a time when many families affected by a difficult economy are struggling with the costs of prescription medications, supermarket retailer Giant Eagle, Inc. is making ten broadly used generic prescription antibiotics in 46 common dosages available for free every day at all of its 210 in-store pharmacies. The major consumer wellness initiative begins today, Thursday. September 3, with a 2:15 PM kickoff press event at Giant Eagle's Pine Township...

2009-08-27 00:34:12

Researchers say most U.S. cases of typhoid fever are related to travel -- especially the Indian subcontinent. The study, published in the Journal of the American Medical Association, finds more and more typhoid cases are being identified as drug-resistant strains, including nalidixic acid-resistant S Typhi as well as ciprofloxacin-resistant. The researchers raise concerns that strains resistant to fluroquinolones may become more prevalent. Over the last 20 years, emergence of S Typhi strains...

e3610e5c2159cc2462bbeee03ec5c529
2009-08-05 06:45:00

According to new research, a contact lens that gradually dispenses medication to the eye might ease treatment for glaucoma and other eye ailments, assuming it advances past animal testing to human testing. People that use eye drops for conditions like glaucoma medicate their eyes several times a day, which is burdensome and inefficient.  Because of the natural blinking of the eye and tear production, only a little bit of medication is absorbed by the eye.  The authors of the study...

2009-06-23 08:00:00

CHICAGO, June 23 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced that a second non-human primate study involving its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin), showed that a 14-day course of Restanza achieved a 100% survival rate against an inhaled lethal dose of anthrax. All of the animals in the study that received 16 mg/kg once-a-day (the human equivalent dose of 300 mg) of Restanza within 24 hours after...

2009-02-02 05:00:00

- Delivery of 20,000 doses of ABthrax will bring at least $150 million in revenue to HGS - ROCKVILLE, Md., Feb. 2 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has begun delivery of 20,000 doses of its human monoclonal antibody drug ABthrax(TM) (raxibacumab) to the U.S. Strategic National Stockpile for use in the treatment of inhalation anthrax. (Photo: http://www.newscom.com/cgi-bin/prnh/20090202/PH65324 ) (Logo:...

1c8d2e2c510d13cad13a399f9784901e1
2008-12-24 07:15:00

U.S. researchers said on Tuesday that older adults in the United States are taking prescription pills, over-the-counter drugs and dietary supplements in record numbers, and in combinations that could pose serious health risks.Over half of U.S. adults aged 57 to 85 are using five or more prescription or non-prescription drugs, and one in 25 are taking them in combinations that could cause dangerous drug interactions, researchers said.Dr. Stacy Tessler Lindau of the University of Chicago...

2008-12-02 07:00:00

MALVERN, Pa., Dec. 2 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that Ortho-McNeil-Janssen Pharmaceuticals' Levaquin is the preferred quinolone antibiotic among more than half of all general medical-surgical hospitals in the United States. Quinolone antibiotics are used to treat lung, sinus, skin and urinary tract infections caused by numerous bacterial pathogens. "Based...

2008-11-12 18:00:21

Aradigm Corporation (OTCBB:ARDM) (the "Company") today announced financial results for the third quarter and nine months ended September 30, 2008. Revenue for the third quarter was $197,000, compared with revenue of $230,000 for the third quarter of 2007. Revenue in the third quarter of 2008 was primarily the result of expense reimbursement from a third party for the evaluation of the delivery of certain compounds using the AERx(R) delivery system. Total operating expenses for the...

2008-11-12 12:00:31

Novexel, a specialty pharmaceutical company, has initiated Phase II clinical trial of its advanced injectable antibacterial, which combines the company's broad spectrum beta-lactamase inhibitor, NXL104, with cephalosporin antibiotic, ceftazidime. This Phase II trial is a prospective, multicenter, investigator-blinded, randomized study which is designed to evaluate the efficacy, safety, and tolerability of NXL104/ceftazidime versus imipenem cilastatin (Primaxin or Tienam, Merck & Co) in...

2008-11-05 18:00:22

SALVAT announced today the submission of the response to the FDA Approvable Letter for CETRAXAL(R) (Ciprofloxacin 0.2% Otic Solution in Single Dose Containers). In an Approvable Letter received on April 6, 2006, the FDA requested additional data with respect to chemistry, manufacturing, and controls (CMC). SALVAT expects the FDA to classify the complete response as a Class 2 resubmission, under which the FDA will seek to complete its review of the resubmission within 180 days from the...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related